Epidemiology: only few reported cases of pulmonary toxicity
Diagnosis
CXR/Chest CT: interstitial infiltrates
Clinical: abrupt or insidious onset of dyspnea, cough, fever
Treatment/Prognosis: unknown
References
Pulmonary fibrosis following therapy with Melphalan for multiple myeloma. J . clin. Path., 1972, 25, 668-673
Melphalan-associated pulmonary toxicity following high-dose therapy with autologous hematopoietic stem cell transplantation. November 2000, Volume 26, Number 10, Pages 1107-1109
